Monday, November 7, 2011

NOT: Great video re: recent Rituximab findings + Fluge and Mella want nationwide multi-center study to confirm or reject recent findings

This is a good video about the recent Norwegian Rituximab findings, it
will really pump you up. To enable closed captioning in English, click
on the 'CC' button on the bottom of the player. (Note: It appears that
the CC option is only available on the Youtube site so be sure to add
a note if you embed the video on a website, blog, forum, etc)

Norwegian breakthrough in ME-Research [TV2 Nyhetene with English sub]-
http://www.youtube.com/watch?v=3DZBCXKIRBQ-s

-------------------------------------------------

Also, a new article in the Norwegian newspaper says the researchers
want a nationwide multi-center study to confirm or reject the recent
findings and funding is needed-

http://translate.google.com/translate?sl=3Dauto&tl=3Den&js=3Dn&prev=3D_t&hl=
=3Den&ie=3DUTF-8&layout=3D2&eotf=3D1&u=3Dhttp%3A%2F%2Fwww.tv2.no%2Fnyheter%=
2Finnenriks%2Fhelse%2Fvil-sette-i-gang-en-stoerre-nasjonal-mestudie-3630651=
.html
>&tl=3Den&js=3Dn&prev=3D_t&hl=3Den&ie=3DUTF-8&layout=3D2&eotf=3D1&u=3D=
http%3A%2F%2Fwww.tv2.no%2Fnyheter%2Finnenriks%2Fhelse%2Fvil-sette-i-gang-en=
-stoerre-nasjonal-mestudie-3630651.html


NEW ME STUDY: Professor Olav Mella (left) and Dr. =D8ystein Fluge now
wants to launch a major national multi-center study on the effect of
cancer drug Rituximab against ME.

Barbara Eikesdal
barbro.eikesdal@tv2.no
Published 06.11.2011

ME breakthrough
Will launch a major national study, ME

The Bergen-based doctors behind the Norwegian ME breakthrough is now
working to launch a larger study involving many more patients. If the
financing in order, such a study is a step towards a treatment for ME.

In October, let TV 2 on the Norwegian breakthrough that may solve the
riddle ME . The two cancer doctors, Professor Olav Mella and Dr.
=D8ystein Fluge at Haukeland University Hospital in Bergen, has
accidentally discovered a possible treatment of ME, also known as
chronic fatigue syndrome.

Now the doctors want to launch a larger, so-called multi-center study,
the number of university clinics in Norway. Such a study will be a
step towards a treatment for ME.

- If there is a study that is positive and shows a clear effect and
there is no serious, unexpected adverse events, we begin to approach
an approved treatment. It will be many patients benefit, says Dr.
=D8ystein Fluge to tv2.no.

Strong interest from communities
After the study, the doctors were known, several research groups in
Norway have been in contact with the doctors.

=96Several of the university clinics have now taken an academic
initiative to launch a national multicenter study on the effect of
Rituximab against Me, says Professor Fly to tv2.no.

Such a study will be based on the previous study (read the main points
from the ME-study to the right of the article) and a maintenance study
still in progress at Haukeland Hospital. Doctors believe that the
study can be started over the summer.

-We want to spend time on this in order to draw lessons from the
maintenance study, which is now said Fluge.

The results from this study are not public yet, but we see some things
what number of infusions and response pattern applies. We wish to draw
on when we will create designs for the new study.

Need financing
Currently, such a study at the planning level. The initiative is
there, but it will become a reality is doctors rely on funding.

=96Should this study be part of, we are completely dependent on what is
external financing. If we are to rely on funds from the regular
channels, such as RCN, so it may take years before we get to
something, says Professor Mella to tv2.no.

Where the funding will come from is not yet clear, but doctors hope
for help from the state.

=96We will certainly try to dialogue with government authorities on
external financing, says Mella.

TV 2 has previously written about the Health Minister Anne-Grete
Str=F8m-Erichsen, who promised to follow ME-breakthrough .

Stringent requirements to be included in the study
Influx of ME patients have been tremendous and overwhelming to Fly and Mell=
a.

=96 I have received hundreds of emails and people calling right on my
cell phone, said Fluge.

=96 Now that you are working to initiate a new study, many will wonder
how they can make. What can you say about who should be included?

=96 Shall we have a study in which we are sure to get the result we must
be very clear on the criteria. They must be crystal clear, says Mella.

This is particularly important as it will be different physicians at
different centers to take care of patients. Fly and Mella wants to use
the so-called Canadian criteria .

=96 We will go to the rigorous criteria. It shall be the greatest
possible chance that the patients included really have ME and general
exhaustion, said Fluge.

He also points out that all will be served by a careful selection process.

=96If it then would be a study that is positive and shows a clear effect
and there is no serious, unexpected adverse events, we begin to
approach that this may be an approved treatment. It will be many
patients benefit, says Fly to tv2.no.

---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------